Jones Day advised Debiopharm Innovation Fund, M Ventures, and Omnes Capital on the deal.Iktos, a Paris, France-based company specializing in artificial intelligence for new drug discovery,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
